Health Care/Hospital

Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII

SHANGHAI, Nov. 18, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the final closing of Qiming Venture Partners Fund VII, a$1.2 billion fund focuses on early-stage Healthcare and TMT investments. As of today, this is the largest VC fund raising in 2020 which primarily focuses onChina...

2020-11-18 21:15 2685

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business unit of WuXi AppTec offering end-to-end contract services for the cell and gene therapies industry – today announced the completion of a facility expansion that will triple its advanced testing capaci...

2020-11-18 21:00 1519

Colombian Fertility Center Achieves Global Healthcare Accreditation

WEST PALM BEACH, Florida, Nov. 18, 2020 /PRNewswire/ -- InSer (Center of Human Fertility)https://www.inser.com.co/en/ in Medellín, Colombia has been awarded a three-year term of accreditation by the Global Healthcare Accreditation (GHA) Program (http://globalhealthcareaccreditation.com/) for its ...

2020-11-18 20:00 1654

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially began construction of its Plant 4 in Incheon,South Korea. Dubbed the "Super Plant," the new, multi-story 238,000-square-meter construction will be the world's largest biopharmaceutical manufacturing ...

2020-11-18 20:00 1547

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results

HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2020-11-18 20:00 7418

HistoIndex's AI-Based Platform Demonstrates Zonal Quantification and Histological Characterization of Fibrosis Improvements in Patients With Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Nov. 18, 2020 /PRNewswire/ -- HistoIndex 's Second Harmonic Generation (SHG) stain-free digital pathology platform for the automated quantitative assessment of histological features has shown promising analyses that indicate post-treatment improvements...

2020-11-18 20:00 1430

Informa Markets's Three Iconic Beauty Shows in ASEAN Converge to Bring Beauty Space, An International Virtual Event for Beauty Businesses

KUALA LUMPUR, Malaysia, Nov. 18, 2020 /PRNewswire/ -- Informa Markets, in its dedication to its mission of providing marketplace participants around the globe with opportunities to engage, experience, and do business – for the first time ever, three of its iconic ASEAN beauty shows inMalaysia (...

2020-11-18 19:06 2118

Change in Use of Proceeds From the Global Offering for Expansion of R&D Portfolio into Hepatitis B Clinical Cure and NASH

HANGZHOU, China and SHAOXING, China, Nov. 18, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that the board of directors of the Company (the "Board") resolved to change the use of the remaining Net Proceeds from the Global Offering. (see announcement: https://www....

2020-11-18 17:00 6658

As COVID-19 Recovery Numbers Increase, Government Emphasise the Importance of Maintaining the Body's Immunity

* Decrease the risk of infection with 3 effective acts to increase the body's immunity ahead of the COVID-19 vaccine. * Early detection of symptoms is key to overcoming a COVID-19 case. * With a disciplined approach, Indonesia can overcome the pandemic. JAKARTA, Indonesia, Nov. 18, 2020 /PRN...

2020-11-18 16:47 1365

Chinese biotech company releases rapid COVID-19 antigen test with easy-to-use nasal swab

BINHAI, China, Nov. 18, 2020 /PRNewswire/ -- JOYSBIO Biotechnology Co., Ltd. announced today that they have introduced a new rapid COVID-19 antigen test kit available to medical facilities around the world as well as direct-to-consumer for at-home testing depending on local legislation. The kit ...

2020-11-18 16:38 2094

Cipla launches 'Covi-G' for COVID-19 rapid antibody detection

MUMBAI, India, Nov. 18, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with aBelgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across most Emergin...

2020-11-18 16:36 3567

Taiwanese Design Lands in The National Science and Technology Fair in Thailand

TAIPEI, Nov. 18, 2020 /PRNewswire/ -- From November 13th to November 23th this year, The National Science and Technology Fair inThailand is held in The National Science Museum inBangkok. Expecting nearly 60,000 visitors in 11 days, over 100 technology-related organizations occupy about 20,000 squ...

2020-11-18 16:32 2279

Establishment of Bo'ao Winhealth Rare Disease Medical Center in Hainan Province

BOAO, China, Nov. 18, 2020 /PRNewswire/ -- On November 14th, 2020, Bo'ao Winhealth Rare Disease Medical Center was officially launched, jointly built by Hainan Bo'ao International Medical Tourism Pilot Zone Administration, Winhealth Pharma Group (HK) and Bo'ao Worldlight Hospital. Main leaders of...

2020-11-18 10:00 2346

Kazia Presents Further Paxalisib Data At Sno, Confirming Earlier Positive Safety And Efficacy Signals In Glioblastoma

SYDNEY, Nov. 18, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a summary of new paxalisib data presented at the Society for Neuro-Oncology (SNO) Annual Meeting, which is being held virtually from...

2020-11-18 07:39 2960

Alzheimer's Disease Data Initiative launches new AD Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer's disease and related dementias

Platform gives scientists open access to more data and new tools SEATTLE, Nov. 18, 2020 /PRNewswire/ -- Launching today is the Alzheimer's Disease Data Initiative (ADDI) and its Alzheimer's disease (AD)Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations fo...

2020-11-18 03:20 2039

Sensium Lauded by Frost & Sullivan for Enhancing Patient Outcomes with its Wireless Patient Monitoring Tool

The Sensium System provides accurate and continuous monitoring for early detection of patient deterioration in hospital wards LONDON, Nov. 18, 2020 /PRNewswire/ -- Based on its recent analysis of the European wearable remote patient monitoring market, Frost & Sullivan recognizes TSC Connected Car...

2020-11-18 00:51 1398

Nuance Awarded Frost & Sullivan's 2020 Global Company of the Year Award for Leading the Conversational AI Market

Nuance's future-proof innovations are aimed at reducing clinician burnout and ensuring accurate as well as complete clinical documentation LONDON, Nov. 18, 2020 /PRNewswire/ -- Based on its recent analysis of the global market for AI-powered solutions enabling patient safety in healthcare, Frost...

2020-11-18 00:40 3240

Global leaders welcome the Sanitation and Hygiene Fund as key to increasing investment

GENEVA, Nov. 17, 2020 /PRNewswire/ -- The Sanitation and Hygiene Fund will be critical to dramatically scale up investments to reach everyone with sanitation services, United Nations Deputy Secretary-General has said as the new financial mechanism to drive billions of dollars into the sanitation ...

2020-11-17 23:00 1552

Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM)

MAINLAND CHINA * Regent Pacific to receive a total payment of US$4 million upon the receipt of approval from the National Medical Products Administration (NMPA) for conducting human trial * China is expected to be the single largest market for Sendstend™ UNITED STATES * The Phase II valid...

2020-11-17 22:09 3342

Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform for generative chemistry

HONG KONG, Nov. 17, 2020 /PRNewswire/ -- Following the release of Chemistry42 to a select group of key experts in the pharmaceutical industry in Q3 2020, Insilico Medicine is proud to announce that Merck KGaA, Darmstadt, Germany will be the first launch partner for its flagship generative chemistr...

2020-11-17 22:00 1680
1 ... 597598599600601602603 ... 808